Building Interprofessional Frameworks to Improve Diagnostic and Treatment Paradigms for Patients with Lower-Risk MDS

Building Interprofessional Frameworks to Improve Diagnostic and Treatment Paradigms for Patients with Lower-Risk MDS

Chapel Hill, NC US
November 14, 2025
UNC Lineberger Comprehensive Cancer Center
 
Patients with myelodysplastic syndromes/myelodysplastic neoplasms (MDS) experience significant symptom burden including anemia-related symptoms, problems with physical functioning and dyspnea, fatigue, pain, discomfort, and restricted mobility that, in an older population can contribute to overall frailty and vulnerability. In addition, patients with lower-risk MDS (LR-MDS) are often dependent on regular red blood cell (RBC) transfusions to help manage symptoms of anemia; however, transfusion dependency is extremely burdensome for patients, further affecting their quality of life (QoL).
 
Despite this, MDS continues to be underrecognized and even with novel and emerging therapeutic options, significant delays in diagnosis persist, delaying treatment initiation and negatively affecting patient outcomes. Reducing the time to diagnosis and improving individualized treatment of lower risk LR-MDS requires a collaborative, interprofessional team that will all work together to improve diagnosis, risk stratification, molecular testing, optimal and individualized treatment, and enhanced symptom management.
 
Using expert-developed, peer-reviewed content, specialists at cancer centers will facilitate a 1-hour learning and action planning program with their clinical team to interpret the latest evidence, enhance their treatment regimens, and establish multidisciplinary practices to improve the delivery of personalized medicine for patients with LR-MDS.
 
Educational Partner: Academy for Continued Healthcare Learning (ACHL)

Commercial Support: Support for this activity has been provided through an educational grant from Geron Corporation.

Target Audience

This educational activity is designed for hematologists/oncologists, pathologists, advanced practice providers and nurses in hematology practice, internists, primary care physicians, clinical/oncology pharmacists, and other members of the multidisciplinary team.

Learning Objectives

Upon completion of this activity, learners will be able to:

  • Integrate evidence-based approaches to support earlier, more accurate diagnosis and classification of myelodysplastic syndromes (MDS)
  • Develop clinical frameworks to distinguish patient- and disease-related factors that affect risk stratification
  • Individualize treatment selection for patients with LR-MDS considerate of latest evidence around novel and emerging therapies
  • Develop clinical pathways to facilitate patient-clinician communication and ongoing multidisciplinary care for patients with LR-MDS
Additional information
ACGME/ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Interpersonal and Communication Skills
For more information, please contact:
CME Coordinator Contact Name: 
ACHL
CME Coordinator Contact Phone: 
877-444-8435 ext 160

You may also be interested in

2026 Tutorial on Neoplastic Hematopathology: Focus on New Classifications
2026 Tutorial on Neoplastic Hematopathology: Focus on New Classifications
Hyatt Regency Phoenix Hotel | Phoenix, AZ
 
Continuing in the tradition of 40+ years of tutorials, the 2026 course is designed to update physicians on the latest advances in neoplastic hematopathology.
Organ Preservation and Survival in Head and Neck Cancer
alt=""
David Rubenstein Forum | Chicago, IL
 
This activity will enhance participant understanding of both established and emerging strategies in head and neck cancer care.
3rd Annual University of Chicago Multidisciplinary Breast Cancer Symposium
Rita Nanda, MD and Nan Chen, MD headshot
Westin Michigan Avenue Chicago | Chicago, IL
 
This activity will enhance breast cancer care by providing clinicians with up-to-date, evidence-based strategies across medical, surgical, reconstructive, and radiation oncology.
Summary
Event starts: 
11/14/2025 - 11:00am
Event ends: 
11/14/2025 - 12:00pm
Activity opens: 
11/14/2025
Activity expires: 
02/14/2026
Add to calendar: 
UNC Lineberger Comprehensive Cancer Center
450 West Dr
Chapel Hill, NC 27599
United States
WANT TO KNOW MORE?
Visit the Academy for Continued Healthcare Learning (ACHL) website!
 
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at https://www.achlcme.org/.

The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
FACULTY
  Anand Patel, MD
  Assistant Professor of Medicine, Section of Hematology/Oncology
  Medical Director, Inpatient Leukemia Service, Hematology-Oncology
  University of Chicago
  Chicago, IL
 
 
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Chicago Pritzker School Of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion as AAPA, AANP, and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.
REGISTRATION: For more information, visit the ACHL website or click the button below!
 
Please login or create an account to proceed.